Literature DB >> 15525449

Investigation into the mast cell stabilizing activity of nature-identical and synthetic indanones.

Neil Frankish1, Ronan Farrell, Helen Sheridan.   

Abstract

As part of an ongoing search for novel molecules with therapeutic potential we examined the mediator release inhibition activity of a number of indanones and their derivatives. The aldol condensation product 18 was approximately twice as potent as disodium cromoglycate as an inhibitor of compound 48/80-stimulated histamine release from rat peritoneal mast cells. The activity of this class of dimeric indanone compound is significantly higher than controls and may represent a new class of mast cell stabilizing agents. Compound 18 has been selected for further biological evaluation of its mast cell stabilization profile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525449     DOI: 10.1211/0022357044661

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

Review 1.  Twenty-first century mast cell stabilizers.

Authors:  D F Finn; J J Walsh
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

2.  N-Cyclo-pentyl-N-(3-oxo-2,3-dihydro-1H-inden-1-yl)acetamide.

Authors:  Tao Zhang; Tom McCabe; Bartosz Marzec; Neil Frankish; Helen Sheridan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-03

3.  Molecular structure studies of (1S,2S)-2-benzyl-2,3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol.

Authors:  Tao Zhang; Krzysztof Paluch; Gaia Scalabrino; Neil Frankish; Anne-Marie Healy; Helen Sheridan
Journal:  J Mol Struct       Date:  2015-03-05       Impact factor: 3.196

4.  2-(Di-phenyl-methyl-idene)-2,3-di-hydro-1H-inden-1-one.

Authors:  Tao Zhang; Vilmar Bandero; Tom McCabe; Neil Frankish; Helen Sheridan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-24

5.  The indane diastereoisomers, PH2 and PH5: divergence between their effects in delayed-type hypersensitivity models and a model of colitis.

Authors:  Neil H Frankish; Brendan McHale; Helen Sheridan
Journal:  J Pharm Pharmacol       Date:  2017-10-23       Impact factor: 3.765

6.  Bioactive Indanes: Proof of Concept Study for Enantioselective Synthetic Routes to PH46A, a New Potential Anti-Inflammatory Agent.

Authors:  Tao Zhang; Gaia Scalabrino; Neil Frankish; Helen Sheridan
Journal:  Molecules       Date:  2018-06-21       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.